COVID-19 Outcomes in Patients Undergoing B Cell Depletion Therapy and Those with Humoral Immunodeficiency States: A Scoping Review.
Jessica M JonesAiman J FaruqiJames K SullivanCassandra CalabreseLeonard H CalabresePublished in: Pathogens & immunity (2021)
Our work identifies potentially significant predictors of COVID-19 severity in patients with humoral immunodeficiency states and highlights the need for larger studies to control for clinical and biologic confounders of disease severity.